Does CapForce IBD Breakout Opportunities ETF pay a dividend?

Yes. The latest regular dividend was $0.1249 per share (ex-date Dec 31), an annualised yield of 0.29%.

NYSE Arca · BOUT

CapForce IBD Breakout Opportunities ETF (BOUT)

$42.92−1.40%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$42.92▲ 10.18% in range

Sep 29, 2025Low $35.05 · High $48.93Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

CapForce IBD Breakout Opportunities ETF closed at $42.92 on Sep 28, down 1.40%, 12.3% below its 52-week closing high. Volume of 1.7K shares was 0.65× its 20-day average (below normal).

Split-adjusted performance: -4.5% over one month, +9.8% over six months, +11.8% over one year.

Short interest was 24 shares at the Sep 15 settlement, down 89.9% from the prior report (1.0 days to cover).

Market cap—

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield0.29%$0.1249 last paid

52-week range35.05 – 48.93−12.3% from high

Volume1.7K0.65× 20-day avg

Volatility · 60d15.9%Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −1.3%1M −4.5%3M −11.2%6M +9.8%YTD +18.2%1Y +11.8%3Y +41.3%5Y +25.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short24−89.9% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d28.5%of daily volume

News about CapForce IBD Breakout Opportunities ETF

All news →

No recent articles focused on CapForce IBD Breakout Opportunities ETF. 1 articles mention it in passing.

Quick answers

Does CapForce IBD Breakout Opportunities ETF pay a dividend?: Yes. The latest regular dividend was $0.1249 per share (ex-date Dec 31), an annualised yield of 0.29%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology